Medical Researches
Possibly Effective
Based on 70 Researches
We explored how lactobacillus acidophilus can enhance chemodynamic therapy for cancer. By coupling the probiotic with specialized nanosheets loaded with calcium oxide nanoparticles, we observed a notable reduction in tumor size.
This innovative approach led to a significant boost in hydroxyl radical production within the tumor microenvironment, resulting in a remarkable tumor inhibition rate of 96.4%.
The findings suggest that probiotics can help target tumors more effectively and improve treatment outcomes.
Read More
B. lactis shows promise for cancerBifidobacterium lactis ameliorates AOM/DSS-induced inflammation, dysbiosis, and colonic precancerous lesions.
High relevance for cancer research
We explored how Bifidobacterium lactis impacts bowel health, particularly regarding cancer. In a study involving mice with induced precancerous lesions, we found that B. lactis treatment helped reduce weight loss, intestinal damage, and the formation of polyps.
Both the probiotic and its cell-free supernatant improved gut microbiome health and decreased inflammatory responses. This suggests that B. lactis may play a beneficial role in combating bowel cancer through inflammation regulation and microbiome optimization.
Read More
Our exploration into the effects of Lactococcus lactis on cancer treatment revealed promising results. By genetically modifying Lactococcus lactis to produce HuFOLactis, we aimed to enhance immune responses against tumors. This modified variant, combined with the peptide iRGD, helped immune cells penetrate difficult tumor areas more effectively.
In tests, we saw significant immune cell activation and improved tumor-fighting abilities in mouse models, particularly against gastric cancer. When used alongside anti-PD-1 therapy, this combination successfully slowed tumor growth and improved survival rates.
Read More
We explored how a new approach using immunomodulator-boosted Lactococcus lactis can improve in situ cancer vaccination. By delivering specific immune-boosting agents directly into tumors, this treatment helped activate crucial immune cells, leading to a notable decrease in tumor growth and increased survival rates in mice.
The combination of this treatment with a myeloid-derived suppressor cell inhibitor showed even more promising results, allowing for complete tumor inhibition in certain cases. Overall, this innovative strategy appears to be a significant step towards effective cancer therapies.
Read More
We examined the potential of lactococcus lactis, a probiotic found in yogurt and cheese, in fighting colorectal cancer. Through a thorough review of recent studies, we found that this beneficial bacterium can suppress cancer cell proliferation and reduce inflammatory agents linked to cancer.
Specifically, lactococcus lactis was observed to lower levels of substances like interleukin-6 and tumor necrosis factor-alpha, which are involved in cancer development. However, while its effects appear promising, our findings indicate that more extensive research is necessary to confirm its overall effectiveness in cancer treatment without significant side effects.
Read More
User Reviews
Health improvements noticed
I ordered this product in desperation. Due to chronic BV and the challenges of antibiotics, I sought a natural remedy as my wedding anniversary approached. After taking it, my yeast infection cleared up completely. I noticed an improvement in my digestion and overall health, especially regarding cancer lesions that had resolved completely!
Read More
I received this product promptly. I’m pleased as I had previously struggled to find it. Having overcome cancer in 2016 without traditional treatments, I understand the importance of gut health, and this product is vital for my wellbeing.
Significant quality of life improvement
After 11 years of digestive issues from metformin, I have never felt better since starting this probiotic. My mother now takes it for her rectal cancer, and I highly recommend it. My quality of life has drastically improved.